XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 201,827 $ 49,060
Investments in marketable securities 362,556 309,502
Accounts receivable 14,189 9,464
Inventories 6,311 4,623
Prepaid expenses and other current assets 16,151 19,316
Total current assets 601,034 391,965
Property and equipment, less accumulated depreciation of $15,483 and $12,515 at September 30, 2018 and December 31, 2017, respectively 10,659 9,062
In-process research & development 23,000 23,000
Goodwill 197,797 197,797
Other non-current assets 6,099 5,200
Total Assets 838,589 627,024
Current liabilities:    
Accounts payable, accrued expenses, and other current liabilities 54,330 53,890
Deferred reimbursements 2,750 7,750
Contingent consideration payable 8,800 8,400
Total current liabilities 65,880 70,040
Deferred reimbursements 14,156 14,156
Convertible notes 172,186 164,167
Senior secured term loan 146,622 0
Contingent consideration payable 19,300 17,000
Deferred income taxes 6,465 6,465
Other non-current liabilities 3,029 2,346
Total liabilities 427,638 274,174
Commitments and contingencies
Stockholders’ equity:    
Common stock, $0.01 par value, 500,000,000 and 250,000,000 shares authorized, 189,254,341 and 166,989,790 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively 1,941 1,721
Additional paid-in capital 1,731,174 1,400,758
Accumulated other comprehensive loss:    
Foreign currency translation adjustment (875) (1,659)
Unrealized gain on available-for-sale securities (211) (436)
Warrants 13,063 16,076
Accumulated deficit (1,334,141) (1,063,610)
Total stockholders’ equity 410,951 352,850
Total Liabilities and Stockholders’ Equity $ 838,589 $ 627,024